Niti Aayog Wants Pharma Companies To Ramp Up R&D Spend
Published on: June 24, 2026, 12:03 a.m. | Source: Deccan Chronicle
The Niti Aayog report highlighted several structural constraints that discourage innovation and long-term investment. Repeated pre-grant oppositions and unclear timelines for their disposal delay patent grants, creating uncertainty for innovators. Limited technology transfer and weak industry–academia linkages reduce the commercialisation of public research
